GR3024007T3 - A method of making biocompatible capsules containing cells. - Google Patents
A method of making biocompatible capsules containing cells.Info
- Publication number
- GR3024007T3 GR3024007T3 GR970401661T GR970401661T GR3024007T3 GR 3024007 T3 GR3024007 T3 GR 3024007T3 GR 970401661 T GR970401661 T GR 970401661T GR 970401661 T GR970401661 T GR 970401661T GR 3024007 T3 GR3024007 T3 GR 3024007T3
- Authority
- GR
- Greece
- Prior art keywords
- gum
- cells
- pct
- droplets
- solution
- Prior art date
Links
- 239000002775 capsule Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 5
- 239000003638 chemical reducing agent Substances 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 239000012528 membrane Substances 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- 239000000725 suspension Substances 0.000 abstract 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 abstract 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- 229940072056 alginate Drugs 0.000 abstract 1
- 235000010443 alginic acid Nutrition 0.000 abstract 1
- 229920000615 alginic acid Polymers 0.000 abstract 1
- 125000000129 anionic group Chemical group 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 125000002091 cationic group Chemical group 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- VHJLVAABSRFDPM-ZXZARUISSA-N dithioerythritol Chemical compound SC[C@H](O)[C@H](O)CS VHJLVAABSRFDPM-ZXZARUISSA-N 0.000 abstract 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical group SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 210000004153 islets of langerhan Anatomy 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919117980A GB9117980D0 (en) | 1991-08-20 | 1991-08-20 | A method of making biocompatible capsules containing cells |
| GB929207143A GB9207143D0 (en) | 1992-04-01 | 1992-04-01 | A method of making biocompatible capsules containing cells |
| PCT/GB1992/001511 WO1993003710A1 (en) | 1991-08-20 | 1992-08-14 | A method of making biocompatible capsules containing cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3024007T3 true GR3024007T3 (en) | 1997-10-31 |
Family
ID=26299426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR970401661T GR3024007T3 (en) | 1991-08-20 | 1997-07-08 | A method of making biocompatible capsules containing cells. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5529913A (el) |
| EP (1) | EP0599942B1 (el) |
| JP (1) | JPH06510035A (el) |
| AT (1) | ATE152616T1 (el) |
| AU (1) | AU2443392A (el) |
| CA (1) | CA2115664A1 (el) |
| DE (1) | DE69219606T2 (el) |
| DK (1) | DK0599942T3 (el) |
| ES (1) | ES2101863T3 (el) |
| GR (1) | GR3024007T3 (el) |
| IL (1) | IL102785A (el) |
| MX (1) | MX9204831A (el) |
| WO (1) | WO1993003710A1 (el) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9414304D0 (en) * | 1994-07-15 | 1994-09-07 | C V Lab Ltd | Fibres, manufacture and use |
| WO2000031267A1 (en) * | 1998-11-20 | 2000-06-02 | The Autonomous University Of Barcelona | Insulin production by engineered muscle cells |
| US6921412B1 (en) | 1999-05-18 | 2005-07-26 | Cryolife, Inc. | Self-supporting, shaped, three-dimensional biopolymeric materials and methods |
| AU3458301A (en) * | 2000-01-25 | 2001-08-07 | Edwards Lifesciences Corporation | Bioactive coatings to prevent tissue overgrowth on artificial heart valves |
| CA2421036A1 (en) | 2000-09-20 | 2002-03-28 | Islet Sheet Medical Llc | Fabrication of thin sheet bio-artificial organs |
| CA2425935C (en) * | 2000-11-07 | 2011-03-29 | Cryolife, Inc. | Expandable foam-like biomaterials and methods |
| US20060246111A1 (en) * | 2005-04-19 | 2006-11-02 | Smith Larry L | Polysaccharides as ultrasound transmission media |
| CA2831184A1 (en) * | 2011-03-29 | 2012-10-04 | Myriam Lee Willy Bomans | Method for encapsulated therapeutic products and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO158284C (no) * | 1981-03-13 | 1988-08-17 | Damon Biotech Inc | Fremgangsmaate for selektiv oppbrytning av en permeabel membran. |
| EP0301777A1 (en) * | 1987-07-28 | 1989-02-01 | Queen's University At Kingston | Multiple membrane microencapsulation |
| US4923645A (en) * | 1987-11-16 | 1990-05-08 | Damon Biotech, Inc. | Sustained release of encapsulated molecules |
-
1992
- 1992-08-11 IL IL102785A patent/IL102785A/en not_active IP Right Cessation
- 1992-08-14 AU AU24433/92A patent/AU2443392A/en not_active Abandoned
- 1992-08-14 US US08/196,072 patent/US5529913A/en not_active Expired - Fee Related
- 1992-08-14 DE DE69219606T patent/DE69219606T2/de not_active Expired - Fee Related
- 1992-08-14 DK DK92917748.3T patent/DK0599942T3/da active
- 1992-08-14 ES ES92917748T patent/ES2101863T3/es not_active Expired - Lifetime
- 1992-08-14 EP EP92917748A patent/EP0599942B1/en not_active Expired - Lifetime
- 1992-08-14 CA CA002115664A patent/CA2115664A1/en not_active Abandoned
- 1992-08-14 JP JP5504185A patent/JPH06510035A/ja active Pending
- 1992-08-14 WO PCT/GB1992/001511 patent/WO1993003710A1/en not_active Ceased
- 1992-08-14 AT AT92917748T patent/ATE152616T1/de not_active IP Right Cessation
- 1992-08-20 MX MX9204831A patent/MX9204831A/es not_active IP Right Cessation
-
1997
- 1997-07-08 GR GR970401661T patent/GR3024007T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0599942B1 (en) | 1997-05-07 |
| DE69219606T2 (de) | 1997-09-04 |
| ATE152616T1 (de) | 1997-05-15 |
| AU2443392A (en) | 1993-03-16 |
| IL102785A (en) | 1998-06-15 |
| JPH06510035A (ja) | 1994-11-10 |
| IL102785A0 (en) | 1993-01-31 |
| US5529913A (en) | 1996-06-25 |
| DK0599942T3 (da) | 1997-11-03 |
| EP0599942A1 (en) | 1994-06-08 |
| MX9204831A (es) | 1993-07-01 |
| DE69219606D1 (de) | 1997-06-12 |
| CA2115664A1 (en) | 1993-03-04 |
| WO1993003710A1 (en) | 1993-03-04 |
| ES2101863T3 (es) | 1997-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4673566A (en) | Microencapsulation of living tissue and cells | |
| US4609551A (en) | Process of and material for stimulating growth of cartilage and bony tissue at anatomical sites | |
| US5429821A (en) | Non-fibrogenic high mannuronate alginate coated transplants, processes for their manufacture, and methods for their use | |
| US4689293A (en) | Microencapsulation of living tissue and cells | |
| US4806355A (en) | Microencapsulation of living tissue and cells | |
| Goosen et al. | Optimization of microencapsulation parameters: semipermeable microcapsules as a bioartificial pancreas | |
| CA1215922A (en) | Microencapsulation of living tissue and cells | |
| US4592864A (en) | Aqueous atelocollagen solution and method of preparing same | |
| US6140089A (en) | Chitosan core matrix containing cells encapsulated in a thermoplastic semipermeable membrane | |
| US5855613A (en) | Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change | |
| EP1418228B1 (en) | Macroencapsulated secretory cells | |
| EP0107055B1 (en) | Artificial organs or membranes for medical use | |
| CA2212300A1 (en) | In vitro or in vivo gelfying chitosan and therapeutic uses thereof | |
| JPH0534946B2 (el) | ||
| JPH08502166A (ja) | カプセル化細胞用キトサンマトリックス | |
| JPS6038111B2 (ja) | 固定依存性細胞の培養法 | |
| IL102785A0 (en) | Method of making biocompatible capsules containing cells | |
| EP0233899A1 (en) | Entrapment of anchorage-dependent cells | |
| CA1271438A (en) | Tissue culture and production in permeable gels | |
| Melville et al. | Spare Parts | |
| JPS62262986A (ja) | 表皮細胞培養器 | |
| CA2205446A1 (en) | Biopolymer foams having extracellular matrix particulates | |
| JPH0549335B2 (el) |